ALHC stock climbs as company forecast beats forecast (NASDAQ:ALHC)
The actions of Alignment Healthcare (NASDAQ: ALHC) to have added more than 11% in the aftermarket on Thursday after the Medicare benefit The company released better than expected guidance with its fourth quarter 2021 results.
Total revenue for the quarter increased approximately 23% year-on-year to $298.3 million, supported by growth of approximately 28% year-on-year in premium income from health plans which s amounted to $284.0 million. Membership of the health plan rose about 26% year-on-year to nearly 86,100.
Full-year revenue increased approximately 22% year-on-year to $1.2 billion, with health plan premium revenue increasing approximately 28% year-on-year to $1.1 billion of dollars.
Quarterly net loss attributable to Alignment Healthcare (ALHC) increased approximately 49% year-on-year to $47.8 million, while the medical benefit ratio, which indicates the amount of premium spent on healthcare benefits of health, reached about 86% against about 89% the previous year.
Full-year net loss increased approximately 752% year-over-year to $195.3 million as the medical benefit ratio increased to approximately 88% in 2021 from approximately 83% last year. last year. The cash level reached $466.6 million at the end of the year, indicating growth of approximately 125% year-on-year.
“In 2022, we will continue to invest in new markets and in the replicability and scalability of our differentiated model,” Chief Executive John Kao said.
The company expects health plan memberships to be 93,700 – 93,900 and 97,300 – 99,000 at the end of the first quarter and year 2022, with revenues estimated at 330 – 335 million and $1.330 billion – $1.345 billion, respectively.
On Wall Street, analysts expect Alignment Healthcare (ALHC) to record revenue of $311.74 million and $1.31 billion for the two periods, respectively.